Dr.Kang-ChihFan - AOCE 2026

Dr. Kang-Chih Fan, MD, MMSc, is the Director of Endocrinology and Metabolism at National Taiwan University Hospital Hsinchu Branch and a Clinical Lecturer at National Taiwan University College of Medicine. His research focuses on diabetes, lipid metabolism, and ceramide metabolism, exploring their roles in obesity, gestational diabetes, and long-term metabolic health. He has published in leading endocrinology journals, including the Journal of Clinical Endocrinology and Metabolism (JCEM) & International Journal of Obesity (IJO), and has received multiple academic awards for his contributions.

20 MARCH

Time	Session

10:30 12:00	[Symposium] Diabetes Mellitus (1) Future Management in Diabetes Mellitus Advancing Toward a Cure for Diabetes: Insights from iPSC-Derived Islet Cell Transplantation Trial Daisuke YabeJapan Speaker Advancing toward a Cure for Diabetes: Insights from iPSC-Derived Islet Cell Transplantation TrialIncretin-Based Therapeutics: Bridging Theory and Practice, and Exploring New Horizons AI-Driven Precision Drug Therapy: Tailoring Personalized Treatment for Type 2 Diabetes Kang-Chih FanTaiwan Speaker AI-driven precision drug therapy: Tailoring personalized treatment for type 2 diabetesAnti-Obesity Medications: Clinical Use Closing the Type 2 Diabetes Gap in Cardiovascular and Renal Disease Jenny GuntonAustralia Speaker Closing the Type 2 Diabetes Gap in Cardiovascular and Renal DiseasePeople with type 2 diabetes die, on average, 6-7 years earlier. This is mostly due to excess cardiovascular events. This presentation will discuss options for lowering cardiovascular and renal risk in people with type 2 diabetes.Managing Hyperglycaemia in Patients Receiving Immune Checkpoint InhibitorsIt is estimated that >20% of people treated with Immune Checkpoint Inhibitors (ICI) for their cancer will experience new or worsening hyperglycaemia. This presentation will discuss the differential diagnoses for the cause of hyperglycaemia in people treated with ICI and treatment strategies 101

Time

Session

10:30

12:00

[Symposium] Diabetes Mellitus (1)

Future Management in Diabetes Mellitus

Advancing Toward a Cure for Diabetes: Insights from iPSC-Derived Islet Cell Transplantation Trial

Daisuke YabeJapan Speaker Advancing toward a Cure for Diabetes: Insights from iPSC-Derived Islet Cell Transplantation TrialIncretin-Based Therapeutics: Bridging Theory and Practice, and Exploring New Horizons
AI-Driven Precision Drug Therapy: Tailoring Personalized Treatment for Type 2 Diabetes

Kang-Chih FanTaiwan Speaker AI-driven precision drug therapy: Tailoring personalized treatment for type 2 diabetesAnti-Obesity Medications: Clinical Use
Closing the Type 2 Diabetes Gap in Cardiovascular and Renal Disease

Jenny GuntonAustralia Speaker Closing the Type 2 Diabetes Gap in Cardiovascular and Renal DiseasePeople with type 2 diabetes die, on average, 6-7 years earlier. This is mostly due to excess cardiovascular events. This presentation will discuss options for lowering cardiovascular and renal risk in people with type 2 diabetes.Managing Hyperglycaemia in Patients Receiving Immune Checkpoint InhibitorsIt is estimated that >20% of people treated with Immune Checkpoint Inhibitors (ICI) for their cancer will experience new or worsening hyperglycaemia. This presentation will discuss the differential diagnoses for the cause of hyperglycaemia in people treated with ICI and treatment strategies

101

21 MARCH

Time	Session

08:30 10:00	[DAROC Symposium 1] Obesity Clinical Management of Obesity Clinical Pathways for Obesity Management I-Weng YenTaiwan Speaker Clinical Pathways for Obesity Management Anti-Obesity Medications: Clinical Use Kang-Chih FanTaiwan Speaker AI-driven precision drug therapy: Tailoring personalized treatment for type 2 diabetesAnti-Obesity Medications: Clinical Use Obesity Care in Special Populations Chun Heng Kuo Speaker Obesity Care in Special Populations 102

Time

Session

08:30

10:00

[DAROC Symposium 1] Obesity

Clinical Management of Obesity

Clinical Pathways for Obesity Management

I-Weng YenTaiwan Speaker Clinical Pathways for Obesity Management
Anti-Obesity Medications: Clinical Use

Kang-Chih FanTaiwan Speaker AI-driven precision drug therapy: Tailoring personalized treatment for type 2 diabetesAnti-Obesity Medications: Clinical Use
Obesity Care in Special Populations

Chun Heng Kuo Speaker Obesity Care in Special Populations

102

Dr.Kang-ChihFan Taiwan

20 MARCH

21 MARCH